Experimental ALS drug OK'd by Health Canada Health Canada has approved an experimental drug for amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig's disease, as uncertainty persists about the drug's clinical benefit. June 13, 2022 Labels: CBC | Health News health Share to: Twitter Facebook URL Print Email
Post a Comment